Pfizer announces agreement with Gilead to manufacture remdesivir for treatment of COVID-19
August 07, 2020 – Pfizer Inc. (New York, NY) announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir,…